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a b s t r a c t
Haemorrhagic fever viruses cause emerging infectionsworldwide, and blood or serum is themain sample
used for diagnosis. However, storage and transportation of such samples from remote areas to regional
laboratories may be complicated and expensive. In this study, a novel approach was evaluated for the
detection of Puumala hantavirus (PUUV) RNA and Rift Valley fever virus (RVFV) RNA. Whole-blood sam-
ples spiked with viable virus particles were tested in parallel with clinical samples from patients with
acute haemorrhagic fever with renal syndrome (nephropathia epidemica). Individual blood samples were
spotted on ﬁlter paper, dried, and used for RNA extraction at later time points. PUUV RNA was detectedantavirus
ift Valley fever virus
ilter paper
T-PCR
by RT-PCR after storage at room temperature for up to six weeks. In contrast, only low copy numbers of
RVFV RNA were detected after 1–2 days even though viable RVFV was eluted from the dried ﬁlter papers
after the same time. The use of ﬁlter paper to collect and store blood samples for PUUV RNA detection is
therefore a simple and reliable procedure. This approach might facilitate sampling and analysis of other
RNA viruses from human or animal sources and could be used for ﬁeld studies in remote areas or in
developing countries.. Introduction
Severalmembers of theBunyaviridae family are causative agents
f severe haemorrhagic fevers. Among them are the viruses that
ause Rift Valley fever (RVF) (genus Phlebovirus), Crimean-Congo
aemorrhagic fever (genus Nairovirus), haemorrhagic fever with
enal syndrome (HFRS), and hantavirus pulmonary syndrome
genus Hantavirus) (Ergonul, 2006; Flick and Bouloy, 2005; Jonsson
t al., 2010). RVF is an arthropod-borne viral disease affecting
omestic ruminants and humans. The disease, caused by RVF virus
RVFV), is closely associated with the African continent. Recently,
VF has appeared on the Arabian Peninsula and has consequently
een considered an emerging viral threat to geographic regions
utside of Africa (Flick and Bouloy, 2005; Gerdes, 2004; Moutailler
t al., 2008; Turell et al., 2008).
Puumala hantavirus (PUUV), like other hantaviruses, is trans-
itted to humans by inhalation of rodent excreta. PUUV infection
auses a milder form of HFRS (also denoted nephropathia epidem-
ca). This disease is endemic in Fennoscandia and central parts
f Europe and Russia (Vapalahti et al., 2003). PUUV, other han-
aviruses, and RVFV are capable of causing serious outbreaks with
∗ Corresponding author. Tel.: +46 90 7852309; fax: +46 90 133006.
E-mail address: clas.ahlm@climi.umu.se (C. Ahlm).
166-0934/© 2011 Elsevier B.V. Open access under CC BY-NC-ND license.
oi:10.1016/j.jviromet.2011.09.010© 2011 Elsevier B.V. Open access under CC BY-NC-ND license.
large economic losses, and are of great concern for public health
(Hofmann et al., 2008; Jonsson et al., 2010; Meegan et al., 1979;
Ngukuet al., 2010; Petterssonet al., 2008). In addition, these viruses
are considered to be potential agents of bioterrorism (Sidwell and
Smee, 2003).
The diagnosis of viral haemorrhagic fevers is often done using
blood samples for serology or PCR analysis. However, transporta-
tion of these samples requires a cold chain and rapid transportation
to the laboratory. In addition, there is a risk of accidental expo-
sure to infectious agents when transporting liquid blood samples
in glass vials. Previous studies have shown that ﬁlter paper may
be useful when sampling blood or serum of human or animal ori-
gin for antibody detection (Desbois et al., 2009; El Mubarak et al.,
2004; Olsson et al., 2003). Quantitative real time-PCR (QRT-PCR) is
an attractive method for detection and quantitation of infectious
agents, and it is especially useful for identiﬁcation of viral genomes
during the early phases of an infection (Bird et al., 2007; Drosten
et al., 2002; Evander et al., 2007; Garcia et al., 2001; Näslund
et al., 2008; Xiao et al., 2006). It has been reported previously that
PUUV RNA and RVFV RNA can be detected in blood before anti-
bodies appear (Evander et al., 2007; Näslund et al., 2008). Others
have successfully used ﬁlter paper to test blood samples for the
presence of DNA or RNA of various viruses by PCR (Abdelwhab
et al., 2011; Desbois et al., 2009; Fischer et al., 2004; Katz et al.,
2002; Michaud et al., 2007; Prado et al., 2005), but similar studies
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o detect viruses of the Bunyaviridae family have not yet been
onducted.
The use of ﬁlter paper could facilitate sampling, transportation,
nd storage of samples. However, it is unknown whether such tech-
ologies can be applied to haemorrhagic fever viruses or whether
he virus would still be infectious on dried ﬁlter paper.
The aim of the present study was to evaluate the usefulness of
lter papers for storage and detection of two RNA viruses from the
unyaviridae family, PUUV and RVFV, which are rodent-borne and
osquito-borne viruses, respectively. In addition, we investigated
he potential hazard of viable, infectious RVFV remaining on the
tored ﬁlter papers.
. Materials and methods
.1. Viral strains, cells and patients
The experiments were carried out using either the PUUV strain
meå/hu (accession no. AY526219), isolated from a human host
Johansson et al., 2004; Juto et al., 1997), or the RVFV strain ZH548
accession no. AF134534), isolated in Egypt in 1977 (Sall et al.,
999). Vero E6 cells were used for cultivation and propagation
f PUUV and RVFV. These cells were maintained in Dulbecco’s
odiﬁed Eagle’s medium (DMEM) (Invitrogen Inc., Carlsbad, CA)
upplemented with 5% fetal calf serum (Thermo Fisher Scientiﬁc,
altham, MA), 10 mM HEPES, 1 mM  sodium pyruvate, 100 U/ml
enicillin and 100 g/ml streptomycin, at 37 ◦C in a humidiﬁed
tmosphere containing 5% CO2. All manipulations with viable
VFV were performed under BSL 3 conditions. Clinical samples
sed in this study were collected at Umeå University Hospi-
al from patients with serologically veriﬁed PUUV infection. The
tudy was approved by the Research Ethics Committee of Umeå
niversity, Sweden, and all the patients gave their informed
onsent.
.2. Experimental design
Patient serum or whole blood spiked with virus (PUUV or RVFV)
as kept at 4 ◦C or was spotted on Nobuto ﬁlter paper (Advantec,
ublin, CA) and stored at room temperature for different lengths
f time. Nobuto ﬁlter papers were chosen since they have been
sed successfully for PUUV serology in rodents (Olsson et al., 2003).
he ﬁlter papers were eluted with RNAse-free water, RNA was
xtracted, and QRT-PCR was performed to determine the viral copy
umbers. Liquid control samples were diluted and analysed in the
ame way. For RVFV, other brands of ﬁlter paper and absorption
nd elution conditions were tested in an attempt to improve RNA
etection. In addition, the infectivity of RVFV applied to ﬁlter paper
as evaluated.
.3. Sampling on ﬁlter papers
Fifty microliters aliquots of patient sera were added to the
bsorption zones of Nobuto blood ﬁlter papers. The ﬁlter papers
ere dried overnight before being transferred to 15-ml Falcon
ubes and stored at room temperature until extraction of RNA was
one after one day, one week, two weeks, and six weeks. For RVFV
e used two additional brands of ﬁlter paper, Whatman FTA clas-
ic card and Whatman 903 (GE Healthcare, Little Chalfont, UK). The
ffect of pre-soaking the RVFV ﬁlter papers with 100 l carrier RNA
10 g/ml, Qiagen, Venlo, the Netherlands) was also analysed. All
amples were tested in duplicate on three separate occasions, and
he mean and standard deviation were calculated for each sample.l Methods 178 (2011) 186– 190 187
2.4. Elution and extraction of viral RNA
After drying and storing the ﬁlter papers for the times stated
above, the absorption zones of the ﬁlter papers were treated with
500 l of RNAse-free water for 1 h at room temperature with gen-
tle rocking, to elute the sample. In addition, the RVFV-spiked blood
samples spotted on ﬁlter papers were eluted with 500 l PBS, PBS
containing 0.2% Tween-20, or RNAse free water containing 0.2%
Tween-20, under the same conditions as described above. As a con-
trol, 50-l aliquots of patient sera or whole blood spiked with PUUV
or RVFV were diluted to 500 l and kept at 4 ◦C for the same time
as the ﬁlter paper samples, and eluted using the same conditions
as for the corresponding ﬁlter paper sample.
RNA extraction was  done directly from 140 l of the eluted
samples of patient sera or PUUV using the RNeasy mini kit (Qia-
gen). The eluted samples and control samples containing RVFV
were extracted using TRIzol® LS reagent (Invitrogen, Carlsbad, CA).
Brieﬂy, 140 l of the eluate was  shaken vigorously with 420 l of
TRIzol® LS reagent for 30 s before 60 l of chloroform was added for
phase separation. The samples were then centrifuged at 12,000 × g
for 15 min  at 4 ◦C, and the upper aqueous phase (140 l) was col-
lected for RNA isolation using the RNeasy mini kit. The PUUV and
RVFV control samples, kept at 4 ◦C, were treated in the same way
as the corresponding samples on ﬁlter paper, and 140 l was  used
for RNA extraction.
2.5. Reverse transcription and quantitation of viral RNA
Preparation of cDNA was performed as described previously
(Evander et al., 2007). Brieﬂy, 12.5 l of the target viral RNA was
added to 12.5 l of reverse transcriptase (RT) mixture contain-
ing RT-buffer (Invitrogen), 5 mM DTT, dNTPs (500 M),  12 ng/l
random hexamer (GE Healthcare), 200 U M-MMLV reverse tran-
scriptase (Invitrogen), and 20 U RNasin (Invitrogen). The samples
were incubated at 42 ◦C for 45 min  and then at 90 ◦C for 10 min.
The PUUV cDNA was  quantiﬁed using a Taqman assay (Applied
Biosystems, Foster City, CA) as described previously (Evander et al.,
2007). All samples were analysed in duplicate in a ﬁnal volume of
25 l, using a 96-well plate. One microlitre of cDNA was  added to
24 l of Taqman buffer A mixture containing 5 mM  MgCl2, dNTPs
(200 M),  0.25 U AmpErase UNG, 1 U AmpliTaq Gold (Applied
Biosystems), each primer (900 nM), and the 6-carboxyﬂuorescein-
labelled MGB  probe (225 nM). The PCR cycling conditions were
2 min  at 50 ◦C followed by 10 min  at 95 ◦C and then 40 cycles at
95 ◦C for 15 s and 60 ◦C for 60 s.
For RVFV, viral RNA was quantiﬁed as described previously
(Näslund et al., 2008), using an iCycler Thermal Cycler (Bio-Rad
Laboratories, Hercules, CA) and 96-well plates containing SYBR-
green (Biotools B&M Labs, Madrid, Spain). Brieﬂy, 1 l cDNA was
mixed with 10 l SYBR-green, 2 l of each primer (4 pmol), and
RNAse-free water to a ﬁnal volume of 25 l.
All unknown samples were then correlated against a set of
serially diluted in vitro-produced RNA, with quantitative RNA stan-
dards present in all runs. The viral RNA detected by QRT-PCR is
presented as RNA copies/ml of sample, taking into account the
different dilution steps during sample preparation and inherent
dilution effects of the ﬁlter paper used.
2.6. Viability test
Blood samples containing 4800 or 120,000 plaque forming units
(pfu) of RVFV as determined by plaque assay (Näslund et al., 2009)
(equal to 4.8 ×105 and 1.2 × 107 viral RNA copies, respectively)
were spotted on Nobuto ﬁlter papers and stored dry at room tem-
perature for 3, 6, 9, 12, 24, 36, or 72 h before elution with 500 l
RNase-free water. Supernatants (50 l) were added to Vero E6 cells
188 J. Näslund et al. / Journal of Virological Methods 178 (2011) 186– 190
Fig. 1. Detected copies of viral RNA in whole blood spiked with PUUV, dried on
Nobuto ﬁlter papers, and then eluted. The ﬁlter papers were stored for the times
stated (1 day, one week, and two weeks), RNA was eluted, and the quantities of viral
RNA copies were compared to those in control samples containing PUUV-spiked
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Fig. 2. Detected copies of PUUV RNA per ml  in sera from 12 patients with conﬁrmed
PUUV infection. The serum was dried on Nobuto ﬁlter papers, followed by elution.
Viral copies were compared to those for the corresponding serum sample not spot-
corresponding level of CPE. Filter papers spotted with 4800 pfu also
showed signs of infectivity, but it was  less pronounced (Table 1). In
summary, RVF virus spotted on Nobuto ﬁlter papers and stored for
up to 48 h was capable of infecting and killing VeroE6 cells (Table 1).
Table 1
Viability of RVFV dried and stored on Nobuto ﬁlter papers for deﬁned lengths of time
before elution and infection of Vero E6 cells.
Incubation time in cell cultureb
Storage time 2 days 3 days 7 days 14 days
4800 pfua
Controlc ++ +++ +++ +++
3  h − + +++ +++
6  h − − +++ +++
9  h − − + +++
12 h − − + +++
24 h − − + +++
48 h − − − −
72 h − − − −
120,000 pfua
Controlc +++ +++ +++ +++
3  h + +++ +++ +++
6  h + ++ +++ +++
9  h − + +++ +++
12 h − − + +++
24 h − − + +++
48 h − − − +++
72 h − − − −lood that was not spotted on Nobuto ﬁlter papers. The copy numbers indicated
ere adjusted for dilution. The data are presented as mean ± SD from three separate
xperiments performed in duplicate.
rowing in 6-well plates at a cell conﬂuence of approximately 80%.
he cell cultures were observed daily for two weeks for indications
f viral infection. As controls, 4800 and 120,000 pfu of RVFV were
ept at 4 ◦C in 500 l RNAse-free water before 50 l was  added to
ell cultures at the same time points. Because PUUV results in a less
evere illness, grows slowly, and does not cause cytopathic effects
CPE), viability tests were not performed for PUUV (Juto et al., 1997).
. Results
.1. Quantitation of viral RNA in samples eluted from ﬁlter paper
The sensitivities of the PUUV and RVFV QRT-PCR assays have
een described earlier, and the detection limits of diluted in vitro-
roduced standard RNA were found to be about two  and 30 copies,
espectively (Evander et al., 2007; Näslund et al., 2008). When PUUV
as serially diluted in human blood and spotted and dried on ﬁlter
aper, the detection level of PUUV RNA molecules was  estimated to
e approximately 102 copies (data not shown). Unexpectedly, for
VFV, even when using ﬁlter papers spotted with a high RVFV copy
umber (106), the levels of viral RNA copies detected were close to
he detection limit of the QRT-PCR assay (<50 copies). To exclude
he possibility that there was some incompatibility between RVFV
nd Nobuto ﬁlter papers, other brands were tested, but with similar
esults. Different solvents for the elution of viral RNA and pre-
oaking of the ﬁlter papers with carrier RNA were also tried, but
ith no signiﬁcant increase in the levels of RVFV RNA (data not
hown). RVFV RNA was always detected in all non-spotted control
amples using the same incubation times, buffers, and conditions.
.2. Stability of PUUV RNA and RVFV RNA on ﬁlter paper over time
PUUV RNA from Nobuto ﬁlter papers was readily detected by
RT-PCR after several weeks of storage. During the ﬁrst two  weeks,
0–20% of the PUUV RNA copies added to the ﬁlter papers were
etected (Fig. 1). However, a decrease in detection was evident after
ix weeks of storage when only 1% of the initial numbers of PUUV
NA copies were detected (data not shown).
In contrast, when testing the stability of RVFV RNA on ﬁlter
apers, the RVFV copy numbers detected by QRT-PCR were very
ow, even after a relatively short storage time (1–2 days; data not
hown)..3. Clinical samples
To determine the clinical value of using ﬁlter paper as a diag-
ostic method, serum samples were tested from 12 patients withted  on Nobuto ﬁlter paper. The copy numbers indicated were adjusted for dilution.
The  data are presented as mean ± SD from three separate experiments performed
in duplicate.
ongoing PUUV infections. PUUV RNA was detected in all specimens
and the highest number of viral RNA copies eluted from ﬁlter papers
was  approximately 100,000 copies/ml (Fig. 2). In the patients with
a high amount of PUUV RNA in the control samples (patients 9 and
10), between 12% and 16% of viral RNA copies were detected in the
eluate. Interestingly, analysis of samples from patients with lower
copy numbers of viral RNA showed that 25–100% of the PUUV RNA
molecules from the ﬁlter paper were detected (Fig. 2).
3.4. Infectivity of RVFV stored on ﬁlter paper
Control samples of RVFV, not spotted on ﬁlter paper, induced
CPE and killed the cells within 2–3 days. For ﬁlter papers spotted
with 120,000 pfu, and stored in a dry state for 3 or 6 h, the onset of
CPE was delayed by one day compared to the liquid control samples
(Table 1). When we  investigated prolonged storage times (9, 12, 24,
and 48 h) for the ﬁlter papers soaked with blood containing RVFV,
an incubation period of up to two weeks was  necessary to induce aa Number of plaque forming units of RVFV (ZH548) used to spike the blood.
b Level of CPE induced in cell cultures after incubation with ﬁlter strip eluate. +,
++, and +++ indicate relative levels of CPE; − indicates that no CPE was induced.
c The controls were RVFV-spiked human blood samples added directly to cell
cultures.
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. Discussion
Blood sampling is probably the most common means of diag-
osing infectious diseases. However, the drawbacks of using liquid
lood samples are the storage conditions and strict transportation
equirements, which must be sufﬁciently controlled to preserve
he samples before analysis. There is therefore increasing interest
n using other approaches, such as dried blood samples spotted on
lter paper, for the analysis and detection of pathogens. The ﬁlter
apers can be stored at 4 ◦C, or even at higher temperatures, for
everal days before analysis (Lira et al., 2009). The relatively simple
rocedure of applying blood or other ﬂuids to ﬁlter paper for con-
enient storage and/or transportation makes this procedure simple
nd attractive, especially during ﬁeld studies or in low-income
ountries where maintaining the cold chain could be problematic.
ilter papers have been used previously for serological testing and
o carry viral RNA and DNA prior to PCR testing (Abdelwhab et al.,
011; Bellini and Helfand, 2003; Cassol et al., 1992; El Mubarak
t al., 2004; Michaud et al., 2007; Prado et al., 2005).
In this study, two important zoonotic haemorrhagic fevers of
he Bunyaviridae family were evaluated for detection of viral RNA in
ried ﬁlter paper spots of patient sera and blood spiked with viable
irus particles. In the case of PUUV, the results indicated that the
rocedure using ﬁlter paper is useful and that clinical samples can
e stored on Nobuto ﬁlter papers for several weeks before testing
or viral RNA. PUUV RNA stored on Nobuto ﬁlter papers was  rel-
tively stable for up to two weeks. Interestingly, PUUV RNA could
till be detected on ﬁlter papers stored for up to six weeks. When the
riginal patient sample contained high amounts of viral RNA, the
etected levels of eluted RNA was proportionally less which was
ossibly because the ﬁlter papers became saturated when larger
mounts of virus were added to them.
In contrast to the results obtained with PUUV, the levels of RVFV
NA that were detected after storage on Nobuto ﬁlters were unex-
ectedly low and close to the detection limit. Surprisingly, the viral
NA copy number detected was unrelated to the initial amount
f virus used to spike the blood sample. Furthermore, the detec-
ion levels were not improved by using other brands of ﬁlter paper,
ther elution buffers, or pre-treatment of the ﬁlter papers with car-
ier RNA. However, the control samples, kept in a liquid state but
repared in the same manner as the samples incubated on the ﬁlter
apers, did not show the same reduction in RNA copy number.
Residual moisture during the storage of ﬁlter paper could possi-
ly affect RNA detection levels if RVFV is more sensitive to moisture
han PUUV. There may  be other types of ﬁlter papers that allow
etter preservation of RVFV RNA, and future studies that evaluate
ifferent ﬁlter papers with different properties or different proce-
ures when applying, eluting and/or extracting the samples might
ncrease the usefulness of this approach.
Interestingly, it was possible to elute viable RVFV particles from
obuto ﬁlter papers stored for up to 48 h. However, there was  a sub-
tantial decline in virus infectivity over time. These results indicate
hat ﬁlter papers should be handled with caution if they are sus-
ected of carrying pathogenic viruses, which could pose a threat
o human health. Recently, the infectivity of inﬂuenza virus was
hown to be inactivated after adsorption to FTA cards (Abdelwhab
t al., 2011), suggesting that this type of ﬁlter paper may  be useful
or pathogenic virus sampling.
One possible explanation for the observed differences between
he results with PUUV and RVFV may  be the different life cycles
f the viruses. Hantaviruses are transmitted by rodents and infect
umans through inhalation of virus particles from rodent excreta,
hich explains why these viruses show enhanced ex vivo survival
Brummer-Korvenkontio et al., 1980; Gavrilovskaya et al., 1983;
allio et al., 2006; Yanagihara et al., 1985). However, RVFV is found
xclusively within a mosquito vector or an animal host duringl Methods 178 (2011) 186– 190 189
the complete lifecycle and may therefore be less adapted to ex
vivo conditions, and consequently may  be less stable during ﬁl-
ter paper storage. The results suggest that RVFV virions are less
stable under dry conditions than PUUV. Similar differences in tol-
erance to humidity and temperature have been observed earlier
for other Bunyaviridae family members regarding infectivity, e.g.,
Crimean-Congo haemorrhagic fever virus (Nairovirus), Hantaan
virus (Hantavirus), and the Sandﬂy fever Sicilian virus (Phlebovirus)
(Hardestam et al., 2007).
In conclusion, the ﬁlter paper method described above may  facil-
itate ﬁeld sampling of zoonotic RNA viruses in humans and animals,
as shown for PUUV, especially in remote areas and low-income
countries where transportation and storage of biological samples
can be complicated.
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